Acid-Associated Heartburn Symptoms and Dose of Esomeprazole

Study identifier:D9612L00064

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A 4-week Study to Investigate the Relationship Between Resolution of Acid-Associated Heartburn Symptoms and Dose of Esomeprazole Magnesium

Medical condition

Heartburn

Phase

Phase 4

Healthy volunteers

No

Study drug

Esomeprazole magnesium (Nexium)

Sex

All

Actual Enrollment

330

Study type

Interventional

Age

18 Years - 75 Years

Date

Study Start Date: 01 Nov 2004
Primary Completion Date: -
Study Completion Date: 01 Jul 2005

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria